Giorgio Gribaudo
Turin, 10123, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Targeting the US21 viroporin of human cytomegalovirus by calcium channel blockers as a new antiviral strategy.
Journal: Current research in microbial sciences
Published: May 04, 2026
Targeting the human protein disulfide isomerase A3 as a broad-spectrum antiviral approach against human respiratory viruses.
Journal: International journal of antimicrobial agents
Published: November 10, 2025
Fluorescent Isostere (Fluostere) of the Carboxylate: Design of hDHODH Fluorescent Inhibitors as Proof of Concept.
Journal: Journal of medicinal chemistry
Published: June 18, 2025
The natural polyphenol proanthocyanidin A2 prevents the in vitro infection of Ebola virus and rabies virus by interfering with the early phases of the replication cycle.
Journal: Antiviral research
Published: June 03, 2025
Synthesis and multitarget inhibitory effect of indole-based ethyl cinnamate derivatives against SARS-CoV-2 Mpro and cathepsins for broad-spectrum anti-coronavirus activity.
Journal: Bioorganic & medicinal chemistry
Published: March 09, 2025
DHODH inhibitors: What will it take to get them into the clinic as antivirals?
Journal: Antiviral research
Published: December 03, 2024
The Novel A-Type Proanthocyanidin-Rich Phytocomplex SP4™ Acts as a Broad-Spectrum Antiviral Agent against Human Respiratory Viruses.
Journal: International journal of molecular sciences
Published: May 27, 2024
The US21 viroporin of human cytomegalovirus stimulates cell migration and adhesion.
Journal: mBio
Published: July 21, 2023
Synthesis of SARS-CoV-2 Mpro inhibitors bearing a cinnamic ester warhead with in vitro activity against human coronaviruses.
Journal: Organic & biomolecular chemistry
Published: April 20, 2023
Discovery of a Novel Trifluoromethyl Diazirine Inhibitor of SARS-CoV-2 Mpro.
Journal: Molecules (Basel, Switzerland)
Published: November 28, 2022
Last Updated: 09/26/2026